Company
Monash IVF Group Limited
Headquarters: Richmond, VIC, Australia
Employees: 669
CEO: Mr. Michael D. Knaap
Market Cap
A$504.6 Million
AUD as of July 1, 2024
US$336.0 Million
Monash IVF Group Limited Categories
Australia Healthcare Diagnostics & ResearchAustralia Healthcare Australia Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | A$236.0 M |
| EBITDA | A$46.4 M |
| Gross Profit TTM | A$191.2 M |
| Profit Margin | 10.16% |
| Operating Margin | 16.13% |
| Quarterly Revenue Growth | 21.70% |
Stocks & Indices
Monash IVF Group Limited has the following listings and related stock indices.
Stock: ASX: MVF wb_incandescent